Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD).The GoResp Digihaler – which delivers inhaled corticosteroid budesonide and long-acting beta agonist formoterol – has built-in sensors that detect and record data on a patient’s use and […]
